The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

Emergent BioSolutions (EBS) announced that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

Fentanyl’s prevalence in the illicit drug market has made overdoses a universal risk, affecting a wide range of students – ...

The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.

The FDA reveals that phenylephrine, a popular decongestant, is no better than a placebo. Discover what this means for your cold remedy.

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Albany Library is hosting several Narcan trainings in the coming months. With at least one monthly training, the community ...

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.